Novo Nordisk plunges after obesity drug trial disappoints | REUTERS [MX7y8e3AaxE]

Novo Nordisk plunges after obesity drug trial disappoints | REUTERS [MX7y8e3AaxE]

| 1h 28m 28s | Video has closed captioning.

Novo Nordisk said its experimental next-generation obesity drug CagriSema helped patients cut their weight by 22.7% in a late-stage trial, below the 25% it had expected, wiping as much as $125 billion off its market value. #News #novonordisk #wegovyweightloss #ozempic #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow Reuters on Instagram: #lets keto gummies dischem #essential oils gummies keto #active keto gummies canada